Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Egoji is a multi-ingredient herbal supplement developed and manufactured by Novell Pharmaceutical Laboratories, a major pharmaceutical company based in Indonesia. The product is formulated to support and maintain the immune system through a combination of four botanical extracts: Lycium barbarum (Goji fruit), Echinacea purpurea, Phyllanthus niruri (Meniran), and Sambucus nigra (Black elderberry). Each of these components contributes to the supplement's immunomodulatory effects; for instance, Echinacea and Phyllanthus niruri are well-known for stimulating phagocytosis and enhancing the body's natural defense mechanisms. While primarily marketed for general immune health, it is also utilized in the context of managing allergies. Egoji is available in oral dosage forms, including capsules and syrup.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Egoji.